The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued 04-10-2012. Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare […]

FDA conducted a safety review and identified 14 cases of seizures linked to vitamin B6 deficiency in patients using drug products containing carbidopa/levodopa. The 14 cases […]

Esta actualización es a manera de seguimiento del Comunicado de la FDA sobre la seguridad de los medicamentos del 4 de febrero del 2012: Importante interacción […]

The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued 5-7-2012. Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare […]

Este informe actualizado se hace en seguimiento al Comunicado de la FDA sobre la seguridad de los medicamentos: Estudio de seguridad en curso de Revlimid (lenalidomida) […]

The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued 05-14-2012. Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare […]

[11-20-2018] The Food and Drug Administration (FDA) is warning that when the multiple sclerosis (MS) medicine Gilenya (fingolimod) is stopped, the disease can become much worse […]

The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued 6-29-2012 Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare […]

Esta actualización se hace a manera de seguimiento al Comunicado sobre la seguridad de los medicamentos de la FDA: Nueva información sobre la prolongación del intervalo […]